Groups | Inadequate response | Remission | Total | P value |
---|---|---|---|---|
Number of patients, % | N = 965 (42.7%) | N = 1,295 (57.3%) | N = 2,260 (100%) | |
Use of resources | Â | Â | Â | Â |
Medical visits | 16.8 (9.1) | 11.1 (8.2) | 13.6 (8.9) | <0.001 |
Laboratory tests: | 0.6 (0.8) | 0.5 (0.7) | 0.5 (0.8) | <0.001 |
Supplemental tests | 0.1 (0.4) | 0.1 (0.3) | 0.1 (0.3) | NS |
Referrals | 0.2 (0.4) | 0.1 (0.4) | 0.2 (0.4) | 0.005 |
Work productivity losses (days) | 20.2 (63.7) | 12.8 (45.5) | 16.1 (54.2) | 0.001 |
Uncorrected cost model (Euros) | Â | Â | Â | Â |
- Healthcare costs | 857.2 | 443.2 | 620.0 | <0.001 |
Medical visits | 383.9 | 253.7 | 309.3 | <0.001 |
Laboratory tests: | 15.0 | 10.3 | 12.3 | <0.001 |
Supplemental tests | 4.3 | 2.2 | 3.1 | <0.001 |
Drugs | 453.9 | 177.1 | 295.3 | <0.001 |
- Non-healthcare costs (productivity) | 1,615.3 | 1,021.5 | 1,275.1 | 0.001 |
Total cost | 2,472.5 | 1,464.8 | 1,895.0 | <0.001 |
Corrected cost model (Euros)* | Â | Â | Difference | Â |
Healthcare costs | 826.1 | 451.2 | 374.85 | <0.001 |
95% CI | 798.5 - 853.5 | 428.8 - 473.6 | Â | Â |
Non-healthcare costs (productivity) | 1,842.0 | 991.4 | 850.64 | <0.001 |
95% CI | 1,525.7 - 2,158.3 | 733.6 - 1249.1 | Â | Â |
Total cost | 2,668.1 | 1,442.6 | 1,225.49 | <0.001 |
95% CI | 2,346.9 - 2,989.2 | 1,180.9 - 1,704.2 | Â | Â |